四川大学华西第二医院过敏药物全流程管理的优化及效果评价  

Optimization and Effect Evaluation of Full-Process Management of Allergic Drugs in West China Second Hospital,Sichuan University

作　　者：杨春松[1] 杨亚亚[1] 陈力[1] 张伶俐[1] Yang Chunsong;Yang Yaya;Chen Li;Zhang Lingli(Pharmaceutical Department/Evidence-Based Pharmacy Center,West China Second Hospital,Sichuan University,Key Laboratory of Birth Defects and Related Diseases of Women and Children,Sichuan University,Ministry of Education,Chengdu 610041,China)

机构地区：[1]四川大学华西第二医院药学部/循证药学中心,四川大学出生缺陷与相关妇儿疾病教育部重点实验室,成都610041

出　　处：《儿科药学杂志》2023年第10期13-16,共4页Journal of Pediatric Pharmacy

基　　金：四川省科技计划项目(重点研发项目),编号2020YFS0035。

摘　　要：目的:优化妇女儿童医院过敏药物全流程信息化管理,提高患者使用过敏药物的安全性。方法:梳理医院过敏药物全流程管理的不足之处,并结合国家卫生健康委员会《β内酰胺类抗菌药物皮肤试验指导原则(2021年版)》,制定干预措施,优化现有管理模式。结果:更新了医院制度,包括取消头孢菌素常规皮试和制定本院β内酰胺类抗菌药物开具流程;药学部制定过敏药物目录纳入标准及更新过敏药物目录;从医师端、药师端和护理端优化了门急诊及住院医院信息系统(HIS)对过敏药物使用的信息化管理。优化过敏药物全流程管理后青霉素皮试人次、皮试药品数量、皮试费用、皮试阳性率及不良反应数量均无明显变化,而头孢菌素除不良反应发生数量无明显变化外,皮试人次、皮试药品数量、皮试费用、皮试阳性率均明显减少。结论:更新医院制度及优化信息系统有利于促进过敏药物的全流程规范化、信息化管理,提高医院医疗服务质量及患者满意度。Objective:To optimize full-process information management of allergy drugs in women and children’s Hospital,so as to improve the safety of patients using allergic drugs.Methods:Deficiencies in the full-process management of allergic drugs in the hospital were sort out.Intervention measures in accordance with the Guideline for Skin Testing ofβLactam Antibiotics(2021 Edition)by National Health Commission were formulated,and the existing management model was optimized.Results:The hospital policies were updated,including the cancellation of routine skin testing for cephalosporin antibiotics and establishment of prescribing process forβlactam antibiotics.The department of pharmacy formulated the inclusion criteria for the allergy drug list and updated the allergy drug list.The information management of allergic drugs by hospital information system(HIS)in outpatient,emergency and inpatient was optimized from the clinician,pharmacist and nursing perspectives.After optimizing the full-process management of allergic drugs,there were no significant changes in the number of penicillin skin tests,quantity of test drugs,cost of testing,positive rate of skin tests,and incidence of adverse drug reactions.In contrast,cephalosporins showed significant decrease in the number of skin tests,quantity of test drugs,cost of testing and positive rate of skin tests,except for the incidence of adverse drug reactions,which did not change significantly.Conclusion:By updating institutional policies and optimizing information system,it is beneficial to promote standardized and information-based management of allergic drugs throughout the full-process,which helps improve the quality of medical services in the hospital and enhances patients’satisfaction.

关 键 词：过敏药物 头孢菌素 皮试 

分 类 号：R95[医药卫生—药学]